Use this report to: - Gain insight into bionics industry, major types of bionics device and rapidly evolving technologies. - Identify key market dynamics and the factors that may influence the long-term market for bionic devices. - Assess current market trends, drivers and restraints in respect to bionics devices, and analyze their position therein and make key business decisions. - Evaluate the leading market players of bionics devices, their corporate profile and recent developments to draw a competitive landscape for the market leaders.
Highlights - The global market for bionic devices reached $2.8 billion and $3.2 billion in 2015 and 2016 respectively. The market should reach $6.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 15.2% from 2016 to 2021; and $12.1 billion by 2026 at a CAGR of 13.6% from 2021 to 2026. - The bionics market for sensory devices reached $1.7 billion in 2016. The market should reach - $4.1 billion by 2021, growing at a CAGR of 18.9% from 2016 to 2021; and $8.4 billion by 2026 at a CAGR of 15.1% from 2021 to 2026. - The bionics market for limbs and exoskeleton reached $297 million in 2016. The market should reach $550 million by 2021, growing at a CAGR of 13.1% from 2016 to 2021; and $1.1 billion by 2026 at a CAGR of 15.3% from 2021 to 2026.
INTRODUCTION STUDY BACKGROUND There are various definitions of "bionics," which is one of the reasons why estimates of the total size of the market for bionics vary so widely. This BCC Research study defines bionics as all electromechanical devices that are worn on or inside the body and assist the wearer in interacting with the environment (including other humans) by locomoting through it, manipulating or exerting force on it, or perceiving it. Bionics also include certain artificial replacement organs such as hearts, which are vital for the kinds of environmental interactions described above, or which process and eliminate unnecessary or damaging substances taken in from the environment.
Defined in this way, bionic devices overlap, but also are distinct from prosthetics on the one hand, and microelectronic implants on the other. Both of these product categories are covered in other BCC Research reports, such as HLC047E Disabled and Elderly Assistive Technologies and HLC016E Microelectronic Medical Implants: Products, Technologies and Opportunities.
The market for some types of bionic devices, such as artificial hearts and hearing implants, were already relatively well established in 2015 and 2016. Other kinds of bionic devices, such as powered bionic limbs, exoskeletons and eye implants are at earlier stages of commercialization, but appear poised for significant growth over the next decide. The geographical structure of the market is also changing, with the medically advanced countries of North America, the EU and Japan losing some ground to the emerging markets of Asia and elsewhere.
STUDY GOALS AND OBJECTIVES The goal of the report is to examine market opportunities for the bionics industry and the technologies that make possible the more advanced products that are rapidly coming into being.
Specific objectives of the report include analyzing: - Major types of bionic device, both commercial and developmental. - Major markets and market segmentation. - Market drivers and constraints. - Detailed market projections through 2026. - Industry structure, competition and market shares. - Factors that may influence the long-term market for bionic devices.
INTENDED AUDIENCE The report has been written for the entire medical and healthcare interest community, but is tailored especially for readers with an interest in the marketing and management dimensions of bionic devices, such as: - Manufacturers and distributors of bionic devices. - Regulators and health insurers. - Investors. - The financial and analyst community.
SCOPE OF THE STUDY This report covers all types of bionic devices as defined above, but focuses on the following: - Exoskeletons. - Limbs and appendages (e.g., hands, feet, fingers). - Hearts. - Ears. - Eyes.
Certain other types of devices, which fit this report’s definition of bionic, such as bionic penises, are excluded because they are experimental and the potential commercial market for them over the next 10 years is small or non-existent.
Neural implants are covered only to the extent that they form part of an electromechanical system such as a bionic arm, but are excluded if they are purely electronic/electrical in nature (e.g., spinal cord stimulators). Purely mechanical prosthetic devices such as hip implants and assistive devices that are not worn such as wheelchairs are also not covered.
The market projections do not include the cost of surgical procedures used to insert the devices, or rehabilitation or training of wearers in the use of their bionic device.
While some bionic devices are commercially available at present, the real market for bionics is long-term. The report therefore will focus mainly on identifying bionic technologies that are under development and the conditions that will determine which ones reach the market and the quantities that could potentially be sold. Given the long-term nature of the market, the report has a 10-year time frame (i.e., 2016 to 2026).
Since the market for bionic devices will continue to be focused, albeit to a diminishing degree, in the medically advanced countries, the report will present detailed market estimates for the following: the United States and Canada, and the European Union. The rest of the global market will be analyzed as a single unit.
METHODOLOGY AND INFORMATION SOURCES The findings and conclusions of this report are based on information gathered from manufacturers and distributors of bionic devices, hospitals, doctors and other end users. Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature and online databases to produce the baseline market estimates contained in this report.
The base year for analysis and projection is 2015. At the time this report was written, in the early months of 2017, many data for 2016 were not yet available.
With 2015 as a baseline, market projections were developed for 2016 through 2026. These projections are based on a combination of a consensus among the primary contacts combined with our understanding of the key market drivers and their impact from a historical and an analytical perspective. A description of the analytical methodologies used accompanies the detailed market projections, below.
All dollar projections presented in this report are in 2015 constant dollars.
ANALYST'S CREDENTIALS The author of this report is Andrew McWilliams. Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm 43rd Parallel LLC, is the author of several other BCC Research studies of assistive technologies, healthcare and related industries, including HLC047E Disabled and Elderly Assistive Technologies; HLC016E Microelectronic Medical Implants: Products, Technologies and Opportunities; BIO072A Biotechnologies for Medical Applications: Global Markets; HLC072C Global Markets and Technologies for Medical Lasers; HLC014H Global Markets for Telemedicine Technologies; HLC082A Emerging Markets for Advanced Medical Technologies; HLC070A Preventive Healthcare Technologies, Products, and Markets; HLC066C Medical Automation Technologies, Products and Markets; HLC036F Medical Robotics and Computer-Assisted Surgery: The Global Market; HLC051G The Market for Minimally Invasive Medical Devices; HLC038C Patient Monitoring; HLC054D Global Markets and Technologies for Home Medical Equipment; HLC048E Healthcare Information Technology; HLC058A Global Medical Markets for Nanoscale Materials and Devices; HLC045A Prosthetics, Orthotics, and Cosmetic Enhancement Products; HLC185A Health Self-Monitoring: Technologies and Global Markets; IAS027D MEMS: Biosensors and Nanosensors; and SMC051D Microelectromechanical Systems (MEMS) Technology: Current and Future Markets.
Our reports have been used by over 10K customers, including:
KEY FINDINGS Cannabis is a psychoactive drug which is mainly used for medicinal and recreational purposes. The global cannabis testing market is expected to rise at a CAGR of 11.44% over the forecast period of 2018-2026. The market is mainly being driven by an increase in the number of testing facilities acquired as a strategic...
KEY FINDINGS The Global population health management market is expected to rise at a CAGR of 20.78% over the forecast years of 2018-2026. The key factors driving the market growth are increasing healthcare expenditure, government spending, rising need for cost-effective healthcare for the growing geriatric population, the...
KEY FINDINGS The global text analytics market is predicted to grow at a CAGR of 17.44% during the forecast period of 2018-2026. The major factors contributing to this market growth are increasing industry-specific applications of the market and monetization of social media analytics. MARKET INSIGHTS The...
KEY FINDINGS Over the forecast period of 2018-2026, the global medical lighting market is anticipated to register a CAGR of 5.74%. Factors such as the emergence of a significant number of hospitals in the developing economies, global technological advancements in the medical sector and increased government spending on healthcare...
KEY INSIGHTS The global polyolefin market is expected to register a CAGR rise of 6.81% over the projected years of 2018-2026. Factors like growing demand for polyolefins from the packaging industry, their diverse applications, and easy availability of raw materials at cheaper prices have been chiefly responsible for the...
Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Equine Encephalitis Infection pipeline products. -- DISEASE OVERVIEW--- Equine Encephalitis infection is spread through Clostridium tetani bacteria, which is present...